Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55α/YY1/sST2 signaling axis.

Lax A, Soler F, Del Palacio MJosefa Fer, Pascual-Oliver S, Ballester MRuiz, Fuster JJavier, Pascual-Figal D, Asensio-Lopez MDel Carmen. Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55α/YY1/sST2 signaling axis. Mol Ther Nucleic Acids. 2023;32:704-720.